期刊
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
卷 10, 期 10, 页码 1129-1138出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERI.12.104
关键词
antiviral therapies; broad-spectrum viral entry inhibitors; emerging viruses; high-throughput screening; viral entry
资金
- National Institute of Allergy and Infectious Diseases [R01AI074986]
Expert Rev. Anti Infect Ther. 10(10), 1129-1138 (2012) Emerging viral diseases pose a unique risk to public health, and thus there is a need to develop therapies. A current focus of funding agencies, and hence research, is the development of broad-spectrum antivirals, and in particular, those targeting common cellular pathways. The scope of this article is to review screening strategies and recent advances in this area, with a particular emphasis on antivirals targeting the step of viral entry for emerging lipid-enveloped viruses such as Ebola virus and SARS-coronavirus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据